Expanded-Access Use of Elamipretide In A Patient With Membrane Protein-Associated Neurodegeneration

Authors

Jorge Patino
Anna Haertling Clearman
Lindsey Miller
Mary Kay Koenig

Language

English

Publication Date

7-1-2024

Journal

Clinical Case Reports

DOI

10.1002/ccr3.9116

PMID

38919884

PMCID

PMC11196835

PubMedCentral® Posted Date

June 2024

PubMedCentral® Full Text Version

Post-print

Abstract

This case report presents a progressively declining 17-year-old patient with membrane protein-associated neurodegeneration who demonstrated symptomatic improvements in her dysarthria, dysphagia, and gait, and objective improvements in her 6-minute walk test and 5 times sit-to-stand test during elamipretide treatment.

Keywords

case report, elamipretide, MPAN, NBIA

Published Open-Access

yes

Recommended Citation

Patino, Jorge; Clearman, Anna Haertling; Miller, Lindsey; et al., "Expanded-Access Use of Elamipretide In A Patient With Membrane Protein-Associated Neurodegeneration" (2024). Faculty, Staff and Student Publications. 2239.
https://digitalcommons.library.tmc.edu/uthmed_docs/2239